7 | Antiviral Agents (Antivirals)IBA
01/2022
-
09/2007 |
7 | Proteins (Proteins, Gene)FDA Link
05/2014
-
08/2008 |
5 | MucinsIBA
10/2012
-
12/2004 |
4 | Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
05/2011
-
12/2009 |
3 | Monoclonal AntibodiesIBA
01/2024
-
03/2016 |
3 | Glycoproteins (Glycoprotein)IBA
01/2022
-
01/2009 |
3 | CytokinesIBA
01/2021
-
05/2005 |
3 | VaccinesIBA
03/2016
-
09/2007 |
3 | Phenobarbital (Luminal)FDA Link
10/2012
-
12/2005 |
3 | N-Acetylneuraminic Acid (Sialic Acid)IBA
12/2011
-
01/2005 |
3 | Neuraminidase (Sialidase)IBA
05/2009
-
01/2005 |
2 | Detergents (Detergent)IBA
01/2022
-
05/2021 |
2 | Interferon Type IIBA
01/2021
-
08/2008 |
2 | ChemokinesIBA
01/2021
-
01/2004 |
2 | Interleukin-6 (Interleukin 6)IBA
06/2011
-
05/2005 |
2 | Hemagglutinins (Hemagglutinin)IBA
02/2011
-
05/2009 |
2 | Chemokine CCL5IBA
05/2005
-
01/2004 |
2 | InterleukinsIBA
05/2005
-
01/2004 |
1 | PalivizumabFDA Link
01/2024 |
1 | P-2165IBA
01/2022 |
1 | Complement System Proteins (Complement)IBA
01/2022 |
1 | (2R,3R,4R,5S)- 6- (((2S,3R,4R,5R)- 2,3,4,5,6- pentahydroxyhexyl)- (2- (4- (sulfanylmethyl)phenoxy)ethyl)amino)hexane- 1,2,3,4,5- pentolIBA
01/2022 |
1 | Angiotensin-Converting Enzyme 2IBA
01/2022 |
1 | Sulfhydryl Compounds (Thiols)IBA
01/2022 |
1 | Reducing AgentsIBA
01/2022 |
1 | molnupiravirIBA
01/2021 |
1 | AntigensIBA
10/2019 |
1 | Vitamin DFDA LinkGeneric
01/2014 |
1 | Proline (L-Proline)FDA Link
01/2014 |
1 | PlasticsIBA
01/2013 |
1 | Messenger RNA (mRNA)IBA
10/2012 |
1 | Sialic AcidsIBA
10/2012 |
1 | NucleotidesIBA
08/2011 |
1 | Interleukin-13IBA
08/2011 |
1 | 4- (2- (4- isopropylbenzamido)ethoxy)benzoic acidIBA
06/2011 |
1 | RNA (Ribonucleic Acid)IBA
06/2011 |
1 | CalnexinIBA
05/2011 |
1 | Small Interfering RNA (siRNA)IBA
05/2011 |
1 | Protein Isoforms (Isoforms)IBA
02/2011 |
1 | Fetal Proteins (Fetoprotein)IBA
12/2010 |
1 | Virulence Factors (Pathogenicity Factors)IBA
08/2010 |
1 | Chloride Channels (Chloride Channel)IBA
08/2010 |
1 | avian influenza A virus hemagglutininIBA
11/2009 |
1 | GTP-Binding Proteins (G-Protein)IBA
10/2009 |
1 | GlycosaminoglycansIBA
10/2009 |
1 | Membrane Glycoproteins (Membrane Glycoprotein)IBA
05/2009 |
1 | Viral RNAIBA
04/2009 |
1 | InflammasomesIBA
04/2009 |
1 | Membrane Proteins (Integral Membrane Proteins)IBA
01/2009 |
1 | Viral ProteinsIBA
01/2009 |
1 | InterferonsIBA
01/2009 |
1 | Green Fluorescent ProteinsIBA
12/2008 |
1 | Caspase 3 (Caspase-3)IBA
09/2008 |
1 | Immune Sera (Antisera)IBA
12/2005 |
1 | Adenosine Triphosphatases (ATPase)IBA
10/2005 |
1 | Adenosine (Adenocard)FDA LinkGeneric
10/2005 |
1 | Adenosine Triphosphate (ATP)IBA
10/2005 |
1 | ImmunosorbentsIBA
05/2005 |
1 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2005 |
1 | RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
05/2005 |
1 | EnzymesIBA
05/2005 |
1 | Interleukin-8 (Interleukin 8)IBA
05/2005 |
1 | enhanced green fluorescent proteinIBA
01/2005 |